COVID-19-related anxiety in phenylketonuria patients

Background. Phenylketonuria (PKU) is an inherited disorder of amino acid metabolism, the treatment of which often requires a special diet to prevent adverse neuropsychiatric outcomes. In the COVID-19 pandemic, which has had a substantial effect on the whole world since the beginning of 2020, PKU patients represent a vulnerable population because they may be dependent on special nutritional products, have limited access to routine care and display increased levels of anxiety. Methods. For this reason, an online questionnaire assessing the anxiety levels and various personal opinions and practices regarding the pandemic was sent to the PKU patients managed at our clinic, who were 12 years of age or older. Ninety-eight patients responded to the questionnaire. Median age of the participants was 19 years. Results. Most patients were compliant with the hygiene and social distancing recommendations regarding the spread of COVID-19. Of the patients, 61.2% felt more anxious since the pandemic. The most common concern was the possibility of not being able to obtain special nutritional products (58.2%). Anxiety level was significantly higher in females. Conclusions. These data suggest that food security is an important issue of concern in PKU patients. In line with the changing world after the pandemic, different strategies should be considered in the management of patients with inborn errors of metabolism, including PKU

___

1. Blau N, van Spronsen FJ, Levy HL. Phenylketonuria. Lancet 2010; 376: 1417-1427.

2. van Spronsen F, Huijbregts SC, Bosch AM, Leuzzi V. Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKUpatients: a start toward standardized outcome measurement across development. Mol Genet Metab 2011; 104(Suppl): S45-S51.

3. Ney DM, Gleason ST, van Calcar SC, et al. Nutritional management of PKU with glycomacropeptide from cheese whey. J Inherit Metab Dis 2009; 32: 32-39.

4. Özalp I, Coşkun T, Ceyhan M, et al. Incidence of phenylketonuria and hyperphenylalaninaemia in a sample of the Turkish newborn population. In: Addison GM, Harkness RA, Isherwood DM, Pollit RJ (eds). Practical Developments in Inherited Metabolic Disease: DNA Analysis, Phenylketonuria and Screening for Congenital Adrenal Hyperplasia. Dordrecht: Springer, 1986: 237-239.

5. Özalp I, Coşkun T, Tokatli A, et al. Neonatal PKU screening in Turkey: 7 years experience in a developing country. Screening 1995; 4: 139-147.

6. Tezel B, Dilli D, Bolat H, et al. The development and organization of newborn screening programs in Turkey. J Clin Lab Anal 2014; 28: 63-69.

7. Ozalp I, Coşkun T, Tokatli A, et al. Newborn PKU screening in Turkey: at present and organization for future. Turk J Pediatr 2001; 43: 97-101.

8. Yilmaz Ö. Fenilketonürili bireylerde diyet fenilalanin toleransının değerlendirilmesi. Ankara: Hacettepe Üniversitesi Sağlık Bilimleri Enstitüsü, 2017.

9. Abstracts presented at the 13th International Congress of Inborn Errors of Metabolism - ICIEM 2017. J Inborn Errors Metab Screen 2017; 5: 1-413.

10. Wang L, Zou H, Ye F, et al. Household financial burden of phenylketonuria and its impact on treatment in China: a cross-sectional study. J Inherit Metab Dis 2017; 40: 369-376.

11. Eijgelshoven I, Demirdas S, Smith TA, van Loon JM, Latour S, Bosch AM. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands. Mol Genet Metab 2013; 109: 237-242.

12. Gramer G, Haege G, Glahn EM, Hoffmann GF, Lindner M, Burgard P. Living with an inborn error of metabolism detected by newborn screening— parents’ perspectives on child development and impact on family life. J Inherit Metab Dis 2014; 37: 189-195.

13. MacDonald A, Smith TA, de Silva S, Alam V, van Loon JM. The personal burden for caregivers of children with phenylketonuria: a cross-sectional study investigating time burden and costs in the UK. Mol Genet Metab Rep 2016; 9: 1-5.

14. Ford S, O’Driscoll M, MacDonald A. Living with phenylketonuria: lessons from the PKU community. Mol Genet Metab Rep 2018; 17: 57-63.

15. Gunduz M, Arslan N, Unal O, Cakar S, Kuyum P, Bulbul SF. Depression and anxiety among parents of phenylketonuria children. Neurosciences (Riyadh) 2015; 20: 350-356.

16. Ashe K, Kelso W, Farrand S, et al. Psychiatric and cognitive aspects of phenylketonuria: the limitations of diet and promise of new treatments. Front Psychiatry 2019; 10: 561.

17. Bilder DA, Noel JK, Baker ER, et al. Systematic review and meta-analysis of neuropsychiatric symptoms and executive functioning in adults with phenylketonuria. Dev Neuropsychol 2016; 41: 245- 260.

18. Liu K, Chen Y, Lin R, Han K. Clinical features of COVID-19 in elderly patients: a comparison with young and middle-aged patients. J Infect 2020; 80: e14-e18.

19. Jordan RE, Adab P, Cheng K. Covid-19: risk factors for severe disease and death. Br Med J 2020; 368: m1 198.

20. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054-1062.

21. Wilder-Smith A, Freedman D. Isolation, quarantine, social distancing and community containment: pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med 2020; 27: taaa020.

22. Roy D, Tripathy S, Kar SK, Sharma N, Verma SK, Kaushal V. Study of knowledge, attitude, anxiety & perceived mental healthcare need in Indian population during COVID-19 pandemic. Asian J Psychiatr 2020; 51: 102083.

23. Sechi A, Macor D, Valent S, et al. Impact of COVID-19 related healthcare crisis on treatments for patients with lysosomal storage disorders, the first Italian experience. Mol Genet Metab 2020; 130: 170-171.

24. Solé G, Salort-Campana E, Pereon Y, et al; FILNEMUS COVID-19 study group Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network. Rev Neurol (Paris) 2020; 176: 507-515.

25. Julian LJ. Measures of anxiety: State-Trait Anxiety Inventory (STAI). Beck Anxiety Inventory (BAI), and Hospital Anxiety and Depression Scale-Anxiety (HADS-A) 2011; 63(Suppl 11): S467-S472.

26. Bini SA, Schilling PL, Patel SP, et al. Digital orthopaedics: a glimpse into the future in the midst of a pandemic. J Arthroplasty 2020; 35: S68-S73.

27. Chung CJ, Nazif TM, Wolbinski M, et al. Restructuring of structural heart disease practice during the Covid-19 pandemic. J Am Coll Cardiol 2020; 75: 2974-2983.

28. Schrag D, Hershman DL, Basch E. Oncology practice during the COVID-19 pandemic. JAMA 2020; 323: 2005-2006.

29. Vaccaro AR, Getz CL, Cohen BE, Cole BJ, Donnally CJ 3rd. Practice management during the COVID-19 pandemic. J Am Acad Orthop Surg 2020; 28: 464-470.

30. Atac O, Ozalp Y, Kurnaz R, Guler OM, Inamlik M, Hayran O. YouTube as an information source during the Coronavirus disease (COVID-19) pandemic: evaluation of the Turkish and English content. medRxiv doi: https://doi.org/10.1101/2020.05.06.200 93468.

31. Wiederhold BK. Using social media to our advantage: alleviating anxiety during a pandemic. Cyberpsychol Behav Soc Netw 2020; 23: 197-198.

32. Rosenberg H, Syed S, Rezaie S. The Twitter pandemic: the critical role of Twitter in the dissemination of medical information and misinformation during the COVID-19 pandemic. CJEM 2020; 22: 418-421.

33. Pappa S, Ntella V, Giannakas T, Giannakoulis VG, Papoutsi E, Katsaounou P. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: a systematic review and meta-analysis. Brain Behav Immun 2020; 88: 901-907.

34. Limcaoco RSG, Mateos EM, Fernandez JM, Roncero C. Anxiety, worry and perceived stress in the world due to the COVID-19 pandemic, March 2020. Preliminary results. medRxiv doi: https://doi.org/10. 1101/2020.04.03.20043992.

35. Zhang J, Lu H, Zeng H, et al. The differential psychological distress of populations affected by the COVID-19 pandemic. Brain Behav Immun 2020; 87: 49-50.

36. Nicola M, Alsafi Z, Sohrabi C, et al. The socioeconomic implications of the coronavirus pandemic (COVID-19): a review. Int J Surg 2020; 78: 185-193.

37. Manderson L, Levine S. COVID-19, risk, fear, and fall-out. Med Anthropol 2020; 39: 367-370.

38. Berry SA, Brown CS, Greene C, Camp KM, McDonough S, Bocchini JA Jr; Follow-up and Treatment (FUTR) Workgroup for the Advisory Committee on Heritable Disorders in Newborns and Children. Medical foods for inborn errors of metabolism: history, current status, and critical need. Pediatrics 2020; 145: e20192261.

39. Coakley KE, Porter-Bolton S, Salvatore ML, Blair RB, Singh RH. Food insecurity in females with phenylketonuria. JIMD Rep 2020; 53: 103-110.

40. Li SH, Graham BM. Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. Lancet Psychiatry 2017; 4: 73-82.

41. de Lijster JM, Dierckx B, Utens EM, et al. The age of onset of anxiety disorders: a meta-analysis. Can J Psychiatry 2017; 62: 237-246.
Turkish Journal of Pediatrics-Cover
  • ISSN: 0041-4301
  • Yayın Aralığı: Yılda 6 Sayı
  • Başlangıç: 1958
  • Yayıncı: Hacettepe Üniversitesi Çocuk Sağlığı Enstitüsü Müdürlüğü
Sayıdaki Diğer Makaleler

The possible association between neonatal morbidities and amniotic fluid pH and electrolyte levels in infants of preeclamptic mothers

Seda YILMAZ SEMERCİ, Sezer ACAR, MERİH ÇETİNKAYA, Burak YÜCEL, Osman Samet GÜNKAYA

Autism spectrum disorder in patients with inherited metabolic disorders-a large sample from a tertiary center

Tuba ÇELEN YOLDAŞ, Elif Nur ÖZMERT, Berrak BİLGİNER GÜRBÜZ, Halil Tuna AKAR, Turgay COŞKUN

Tobacco use among working adolescents and high school students in Turkey: evaluating the effect of the national tobacco control policy

Erkan ÇAKIR, Hakan YAZAN, Burçin NAZLI KARACABEY, Ahmet Hakan GEDİK, Ali ÖZDEMİR, Nezih VAROL, Fazilet KARAKOÇ, Refika ERSU, Bülent KARADAĞ, Elif DAGLI

Motor functions, quality of life and maternal anxiety and depression in children with cerebral palsy of different intelligence levels

Elif AKÇAY, Yaşar TANIR, Serap TIRAŞ TEBER, Birim GÜNAY KILIÇ

Neuropsychiatric lupus in Malaysian children: clinical characteristics, imaging features and 12-month outcomes

Sern Chin LİM, Yusma Lyana Md YUSOF, Bushra JOHARİ, Roqiah Fatmawati Abdul KADİR, Swee Ping TANG

Cockayne syndrome type: a very rare association with hemorrhagic stroke

Başak ATALAY, Mine SORKUN, Elif Yüksel KARATOPRAK

Mesenteric tissue oxygenation status on the development of necrotizing enterocolitis

Hilal ÖZKAN, Nilgün KÖKSAL, MERİH ÇETİNKAYA, Bayram Ali DORUM

The relationship of motor development with sensory processing among infants born very preterm: a prospective case-control study

Özgün KAYA KARA, Hasan Atacan TONAK, Sedef ŞAHİN, Barkın KÖSE, MUTLUAY ARSLAN, Koray KARA

Entero-encephalopathy due to FBXL4-related mtDNA depletion syndrome

Josef FINSTERER

A fatal interstitial lung disease in an anti-melanoma differentiation-associated gene 5 (anti-MDA5) antibody negative patient with juvenile dermatomyositis

Osman YEŞİLBAŞ, Mehmet YILDIZ, Amra ADROVIC, Sezgin ŞAHİN, KENAN BARUT, Özgür KASAPÇOPUR, Can Yılmaz YOZGAT, Irmak TAHAOĞLU, Hakan YAZAN